In more detail0, KRAS mutations were not identified in the plasma of 17 (17.71%) patients with KRAS mutant tumor tissue, whereas no mutations were detected in the tumor tissue of 7 (7.29%) patients with KRAS mutant ctDNA ( Table S1). Here, KRAS is linked to neoplasm.